Parvin Asset Management, LLC
Source: SEC Form 13F · as of Mar 2026Parvin Asset Management, LLC holds 19 biotech & pharma companies tracked by BioSniper, totaling $8.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$8.3M
| Company | Shares | Value |
|---|---|---|
| AMGNAMGEN INC | 5,739 | $2.0M |
| BMYBRISTOL MYERS SQUIBB CO | 18,765 | $1.1M |
| JNJJOHNSON & JOHNSON | 3,270 | $799K |
| ABBVAbbVie Inc. | 3,625 | $788K |
| PMPhilip Morris International Inc | 4,570 | $756K |
| PAHCPHIBRO ANIMAL HEALTH CORP | 11,850 | $655K |
| ABTABBOTT LABORATORIES | 6,050 | $621K |
| MRKMerck & Co., Inc. | 3,025 | $364K |
| ZTSZoetis Inc. | 2,905 | $343K |
| IBRXImmunityBio, Inc. | 40,000 | $307K |
| PRGOPERRIGO Co plc | 19,875 | $213K |
| NVSNovartis AG | 525 | $80K |
| NVONovo Nordisk A/S | 2,015 | $74K |
| RDYDR REDDYS LABORATORIES LTD | 3,800 | $53K |
| ZBHZimmer Biomet Holdings Inc. | 550 | $50K |
| PFEPFIZER INC | 1,300 | $37K |
| GILDGILEAD SCIENCES, INC. | 200 | $28K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 200 | $11K |
| BAXBaxter International Inc. | 620 | $10K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.